Canada markets closed

Quotient Limited (QTNT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.5300-0.0100 (-0.65%)
At close: 04:00PM EST
1.5900 +0.06 (+3.92%)
After hours: 06:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.5400
Open1.5300
Bid1.5300 x 900
Ask1.5500 x 3100
Day's Range1.4500 - 1.5600
52 Week Range1.4500 - 5.5400
Volume513,479
Avg. Volume789,696
Market Cap156.508M
Beta (5Y Monthly)2.39
PE Ratio (TTM)N/A
EPS (TTM)-1.2140
Earnings DateJan. 31, 2022 - Feb. 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.38
  • GlobeNewswire

    Quotient Limited Launches Scientific Advisory Board and Research Programs

    MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countriesQuotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator Initiated research programsQuotient is initiating studies to demonstrate operational value and workflow benefits within the laboratory JERSEY, Channel Islands, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a com

  • Zacks

    Quotient (QTNT) Upgraded to Buy: Here's What You Should Know

    Quotient (QTNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • GlobeNewswire

    Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress

    Received feedback from the European notified body after review of Expanded IH submissionPleased with feedback and expect to submit a response to the questions in the next couple of weeksContinue to expect approval in Q1 CY 2022 JERSEY, Channel Islands, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notified body on the Expanded Immunohematology (IH) submission. The Company